Log In
BCIQ
Print this Print this
 

DiaVacs dendritic cell therapy

  Manage Alerts
Collapse Summary General Information
Company DiaVacs Inc.
DescriptionDendritic cell therapy
Molecular Target
Mechanism of Action 
Therapeutic ModalityCell therapy: Non-stem cell
Latest Stage of DevelopmentPreclinical
Standard IndicationDiabetes
Indication DetailsTreat Type I diabetes
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today